Business Notes: Feb. 21, 2016

Lebanon — Adimab LLC, the Lebanon-based biomedical firm that discovers and develops antibody-based pharmaceuticals has reported isolating “a broad panel of neutralizing anti-Ebola virus antibodies” from a survivor of the recent outbreak in Zaire. The discovery, published online in the journal Science, “describes the first in-depth view into the human antibody response to Ebola virus,” Laura Walker, senior scientist at Adimab and an...

Read More

Our Newspaper Family Includes: